Getz Pharma issues this statement in response to the recent dissemination of false information about its product Risek IV 40 mg injection on electroni
Read MoreIn continuation of its mission to support initiatives that benefit the community and healthcare system, Getz Pharma has joined hands with the National
Read MoreGetz Pharma, in collaboration with Dow University of Health Sciences (DUHS), has announced the launch of the first three courses on their brand new on
Read MoreGetz Pharma Pvt. Ltd.,in partnership with Tabba Heart Institute, announced the launch of Pakistan Study of Premature Coronary Atherosclerosis in Young
Read More